Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads Digital Contract Notes Online Trading Demo News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Bharat Immunological & Biological Corporation Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 524663 border-img ISIN Demat INE994B01014 border-img Book Value -7.54 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap (₹ Cr.) 129.93 border-img P/E 0 border-img EPS 0 border-img Face Value 10
ParticularsMar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)		Mar 2019
(₹)		Mar 2018
(₹)
INCOME :       
Sales Turnover 44.6178.3985.3366.8483.6534.80
Excise Duty 0.000.000.000.000.000.00
Net Sales 44.6178.3985.3366.8483.6534.80
Other Income 2.801.101.681.184.221.39
Stock Adjustments -5.95-0.44-20.1512.9913.550.00
Total Income 41.4679.0566.8681.01101.4236.19
EXPENDITURE :       
Raw Materials 35.7164.9367.7474.3092.7926.97
Power & Fuel Cost 1.351.691.551.851.741.24
Employee Cost 15.3213.8514.4411.379.7810.31
Other Manufacturing Expenses 1.161.391.221.531.173.23
Selling & Administrative Expenses 1.050.730.600.650.450.96
Miscellaneous Expenses 2.530.330.490.530.590.02
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 57.1282.9286.0590.22106.5242.72
Operating Profit -15.66-3.87-19.18-9.22-5.10-6.54
Interest 7.055.604.794.752.001.01
Gross Profit -22.71-9.47-23.97-13.97-7.10-7.55
Depreciation 0.150.210.240.240.280.41
Profit Before Tax -22.86-9.68-24.21-14.21-7.38-7.96
Tax 0.000.000.000.000.000.00
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -5.79-0.93-6.10-3.99-1.58-3.70
Reported Net Profit -17.06-8.75-18.11-10.21-5.79-4.26
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit -17.06-8.75-18.11-10.21-5.79-4.26
Adjustment below Net Profit 0.000.000.000.01-1.020.01
P & L Balance brought forward -49.57-40.82-22.71-12.50-5.69-1.43
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down -66.63-49.57-40.82-22.71-12.50-5.69
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 0.000.000.000.000.000.00
Dividend Per Share(Rs) 0.000.000.000.000.000.00
Earnings Per Share-Unit Curr -3.95-2.03-4.19-2.36-1.340.00
Earnings Per Share(Adj)-Unit Curr -3.95-2.03-4.19-2.36-1.340.00
Book Value-Unit Curr -5.43-1.480.554.747.108.68
Book Value(Adj)-Unit Curr -5.43-1.480.554.747.108.68

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |    Online Grievance Redressal

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 DP: IN-DP-CDSL-203-2003 PMS: INP000001066

Research Entity SEBI Reg No: INH200003109,

Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh